ArticlePharmacoEconomics2021

Comment on "Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome".

Kelly Hollenack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.